| |
|
|  | Make Your First Intervention Last™ Welcome! The hospital and physician sections have been merged to facilitate your navigation throughout our site. A Major Breakthrough in Interventional CardiologyThe CYPHER™ Sirolimus-eluting Coronary Stent is an entirely new interventional therapy that has been shown to dramatically improve clinical outcomes. Since the arrival of stents in 1995, in-stent restenosis has proven to be the major limitation of interventional cardiology, occuring in as many as 30% of patients. The CYPHER™ Sirolimus-eluting Coronary Stent is specifically designed to reduce in-stent restenosis.
| | | | |
Sirolimus-eluting Stent made by Cordis pursuant to a license from Wyeth Pharmaceuticals. |
 |
||
|
| |  |
